Translational Autoimmunity: Treatment of Autoimmune Diseases, Volume Two in the Translational Immunology series, focuses on advances in therapeutic modalities in autoimmune diseases. Efficacy and safety of not only the current biologic therapies, but also novel drug targets are discussed. Therapeutic targeting of B regulatory cells, T regulatory cells, as well as the immunomodulation effects of nanoparticles and organisms are also covered, along with our understanding and future challenges of prognostic significance of treatments in autoimmune diseases.
- Covers the clinical aspects and treatment of autoimmunite diseases
- Meets the needs of basic scientists, clinicians and translational scientists and industry partners
- Mentions each and every key concept after background is drawn
- Supported by a systematic appraisal of the most recent evidence
- Helps students at all academic levels, but is also applicable to scientists who work with autoimmunity
